Article Information
History
- August 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Juliana D. Siqueira1,¶,*,
- Livia R. Goes1,2,¶,
- Brunna M. Alves1,¶,
- Pedro S. de Carvalho1,
- Claudia Cicala2,
- James Arthos2,
- João P.B. Viola4,
- Andréia C. de Melo3,
- Marcelo A. Soares1,
- on behalf of the INCA COVID-19 Task Force^
- 1Programa de Oncovirologia, Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brazil
- 2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
- 3Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil
- 4Programa de Imunologia e Biologia de Tumores, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil
- ↵*Corresponding author: sidoju{at}hotmail.com (JDS)